Latest News

Latest News



FDA Approves First Drug Designed to Prevent Migraine

FDA approves Aimovig injection that is designed to block proteins that perpetuate migraine headaches

Posted 5/30/18 (Wed) read more »

Dr. Nagala Accepts Position to Serve on the Federation of State Medical Boards Audit Committee

Dr. Rupkumar Nagala, MD, appointed to FSMB's Audit Committee

Posted 5/25/18 (Fri) read more »

UND SMHS Medical Students Receive 2018 NDMA Awards

The North Dakota Medical Association is proud to sponsor awards for outstanding medical students who exemplify high scholarship, integrity, leadership and initiative.

Posted 5/22/18 (Tue) read more »

North Dakota Ranks First in Best Places to Practice Medicine

According to the 2018 Medscape Best & Worst Places to Practice rankings, ND ranks first in best places to practice medicine

Posted 5/08/18 (Tue) read more »

Surgeon General Urges Americans to Carry Opioid Overdose-Reversing Medications

U.S. Surgeon General Jerome M. Adams, M.D., M.P.H., urged more Americans to carry a lifesaving medication that can reverse the effects of an opioid overdose.

Posted 4/10/18 (Tue) read more »

Dr. Ranum Receives Emerging Rural Leader Award

Joshua C. Ranum, MD, of West River Health Services in Hettinger, N.D., received the Emerging Rural Leader award at the 2018 Dakota Conference on Rural and Public Health June 14 in Grand Forks. The award recognizes a new professional who has demonstrated tremendous promise for and commitment to improving the health of rural North Dakota residents. For next e-physician?

Posted 4/02/18 (Mon) read more »

Dr. Hoerauf Receives 2018 Rural Health Practitioner of the Year Award

Posted 4/02/18 (Mon) read more »

ND Dept of Health Accepting Applications for Medical Marijuana Manufacturing Facilities

Posted 3/16/18 (Fri) read more »

Medical Marijuana rules Approved by Legislative Administrative Rules Committee

Posted 3/13/18 (Tue) read more »

ND Orthopaedic Society Annual Meeting Well Attended in Grand Forks

Posted 2/14/18 (Wed) read more »

Sorry no Tweets at this time

Follow Us!